Viewing StudyNCT00866281

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-05 @ 9:21 PM
Last Modification Date: 2024-10-26 @ 10:03 AM
Study NCT ID: NCT00866281
Status: TERMINATED
Last Update Posted: 2015-12-22
First Post: 2009-03-19
Brief Title: A Study of the Safety and Preliminary Efficacy of Oral Midostaurin PKC412 in Relapsed or Refractory Pediatric Leukemia
Sponsor: Novartis Pharmaceuticals
Organization: Novartis
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Keywords:
Name View
Acute Myeloid Leukemia View
AML View
Acute Lymphoblastic Leukemia View
ALL View
midostaurin View
PKC412 View
Pediatric relapsed or refractory FLT3 positive Acute Myeloid Leukemia View
Pediatric relapsed or refractory Mixed-lineage leukemia gene rearranged Acute Lymphoblastic leukemia View